(EMAILWIRE.COM, November 21, 2009 ) Dallas, TX - NuVasive, Inc. (NASDAQ:NUVA) corrected 9.02% to $33.80. The stock hit an intraday high and an intraday low of $37.35 and $33.06 respectively. In the last six months the stock went down over 1%. NuVasive, Inc. is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders.

Micromet Inc. (NASDAQ:MITI) plunged 3.23% to $6.90. The stock hit an intraday high and an intraday low of $7.20 and $6.62 respectively. In the last six months the stock went up over 81%. Micromet, Inc. is a biopharmaceutical company developing antibodies for the treatment of cancer, inflammation and autoimmune diseases. Its product development pipeline includes antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies.

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) plunged 8.17% to $9.55 after the company yesterday announced pricing of a public offering of 5,000,000 shares of its common stock at $9.75 per share, resulting in gross proceeds of $48.75 million. All of the shares are being offered by BioCryst pursuant to an effective shelf registration statement previously filed with the Securities and Exchange Commission. BioCryst has also granted the underwriters a 30-day option to purchase up to an aggregate of 750,000 additional shares of common stock to cover over-allotments, if any.

ABOUT http://www.PennyStockPickalert.com

The website alerts investors on Top Stocks that would help investors to generate higher than average returns. These include various types of stocks with huge volume, penny stocks that are moving to the upside quickly, penny stocks with buy signals and companies with news. Our regular Stock pick Alerts helps investors to achieve incredible results in a short amount of time .

Contact Information:
PennyStockPickAlert.com
Robert Wilson
Tel: 214 556 6798
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.